RILUTEK Side Effects

7020927-4 | Haemolytic Anaemia, Jaundice
on Sep 21, 2010 Male patient from DENMARK , 59 years of age, weighting 132.3 lb, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and was treated with Rilutek (View Usage). Patient experienced the following unwanted or unexpected effects: haemolytic anaemia, jaundice (What is jaundice?). Rilutek dosage: 50 Milligram(s).

7018581-0 | Pneumonia
Patient was taking Rilutek (View Usage). Patient had the following side effects: pneumonia (What is pneumonia?) on Jun 18, 2010 from JAPAN Additional patient health information: Female patient , 81 years of age, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?), tachycardia and. Rilutek dosage: . During the same period patient was treated with METHYCOBAL (View Methycobal Review and Methycobal Label ), VASOLAN (View Vasolan Review and Vasolan Label ). Patient was hospitalized.

7018576-7 | Acute Myocardial Infarction
Adverse event was reported on Feb 19, 2010 by a Female patient taking Rilutek (View Usage) (Dosage: ) was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and. Location: JAPAN , 74 years of age, weighting 114.6 lb, After Rilutek was administered, patient had the following side effects: acute myocardial infarction.

6933607-8 |
on Aug 10, 2010 Female patient from UNITED STATES , 62 years of age, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and was treated with Rilutek (View Usage). . Rilutek dosage: .


6870836-6 | Nephrolithiasis
on Jul 21, 2010 Male patient from FRANCE , 18 years of age, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and was treated with Rilutek (View Usage). Patient had the following side effects: nephrolithiasis. Rilutek dosage: .

6749076-7 | Disease Progression, Dyspnoea, Off Label Use, Therapeutic Response Unexpected
Patient was taking Rilutek (View Usage). After Rilutek was administered, patient had the following side effects: disease progression, dyspnoea, off label use, therapeutic response unexpected on May 25, 2010 from UNITED STATES Additional patient health information: Male patient , 67 years of age, . Rilutek dosage: . During the same period patient was treated with ALLEGRA (View Allegra Review and Allegra Label ), ACTONEL (View Actonel Review and Actonel Label ), COMBIVENT /JOR/ (View Combivent /jor/ Review and Combivent /jor/ Label ), VITAMIN D (Dose:50000 Unit(s)) (View Vitamin D Review and Vitamin D Label ), SINGULAIR (View Singulair Review and Singulair Label ), FLUTICASONE PROPIONATE (View Fluticasone Propionate Review and Fluticasone Propionate Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ). Patient was hospitalized.

6741354-0 | Delirium, Electrocardiogram Qt Prolonged, Mental Status Changes
Adverse event was reported on May 17, 2010 by a Male patient taking Rilutek (View Usage) (Dosage: ) . Location: UNITED STATES , 72 years of age, Patient experienced the following unwanted or unexpected effects: delirium, electrocardiogram qt prolonged, mental status changes. During the same period patient was treated with ABILIFY (View Abilify Review and Abilify Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), PAXIL (View Paxil Review and Paxil Label ). Patient was hospitalized.

6727944-X | Bone Disorder, Disease Progression, Fall, Joint Sprain, Pain In Extremity
on May 04, 2010 Male patient from UNITED STATES , 62 years of age, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and was treated with Rilutek (View Usage). Patient had the following side effects: bone disorder, disease progression, fall (What is fall?), joint sprain, pain in extremity. Rilutek dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), DIGOXIN (View Digoxin Review and Digoxin Label ).

6717267-7 | Unevaluable Event
on Apr 26, 2010 Female patient from CANADA , 71 years of age, was treated with Rilutek (View Usage). After Rilutek was administered, patient had the following side effects: unevaluable event. Rilutek dosage: .

6717169-6 | Unevaluable Event
Patient was taking Rilutek (View Usage). Patient experienced the following unwanted or unexpected effects: unevaluable event on Apr 26, 2010 from CANADA Additional patient health information: Female patient , 71 years of age, . Rilutek dosage: .

6706115-7 |
Adverse event was reported on Apr 23, 2010 by a Female patient taking Rilutek (View Usage) (Dosage: ) . Location: CANADA , 71 years of age, .

6669307-1 | Heart Rate Decreased, Hypotension
on Mar 30, 2010 Male patient from UNITED STATES , 72 years of age, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and was treated with Rilutek (View Usage). After Rilutek was administered, patient had the following side effects: heart rate decreased, hypotension. Rilutek dosage: . During the same period patient was treated with METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), COUMADIN (5 Mg And 2.5 Mg Alternating Every Other Day) (View Coumadin Review and Coumadin Label ), ZANAFLEX (View Zanaflex Review and Zanaflex Label ).

6663515-1 | Respiratory Arrest
on Mar 26, 2010 Male patient from AUSTRALIA , 72 years of age, weighting 79.37 lb, was diagnosed with condition aggravated and was treated with Rilutek (View Usage). Patient experienced the following unwanted or unexpected effects: respiratory arrest. Rilutek dosage: . During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ).

6591072-7 | Dizziness, Dry Mouth, Headache, Myalgia, Pyrexia
Patient was taking Rilutek (View Usage). Patient had the following side effects: dizziness (What is dizziness?), dry mouth, headache (What is headache?), myalgia, pyrexia on Feb 10, 2010 from NETHERLANDS Additional patient health information: Male patient , 48 years of age, was diagnosed with motor neurone disease and. Rilutek dosage: . Patient was hospitalized.

6526915-6 | Acute Myocardial Infarction
Adverse event was reported on Dec 25, 2009 by a Female patient taking Rilutek (View Usage) (Dosage: ) was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and. Location: JAPAN , 74 years of age, weighting 114.6 lb, After Rilutek was administered, patient had the following side effects: acute myocardial infarction.

6522674-1 | Pneumonia
on Dec 21, 2009 Male patient from AUSTRALIA , 77 years of age, was diagnosed with motor neurone disease and was treated with Rilutek (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?). Rilutek dosage: . During the same period patient was treated with ACTONEL (View Actonel Review and Actonel Label ), CARTIA /AUS/ (View Cartia /aus/ Review and Cartia /aus/ Label ), HERBAL PREPARATION (View Herbal Preparation Review and Herbal Preparation Label ).

6519447-2 | Agranulocytosis, Anaemia, White Blood Cell Count Decreased
on Dec 22, 2009 Female patient from GERMANY , 73 years of age, weighting 143.3 lb, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?), depression (What is depression?) and was treated with Rilutek (View Usage). Patient had the following side effects: agranulocytosis, anaemia, white blood cell count decreased. Rilutek dosage: . During the same period patient was treated with AMITRIPTYLINE HYDROCHLORIDE/CHLORDIAZEPOXIDE HYDROCHLORIDE (View Amitriptyline Hydrochloride/chlordiazepoxide Hydrochloride Review and Amitriptyline Hydrochloride/chlordiazepoxide Hydrochloride Label ).

6503422-8 | Pneumonia
Patient was taking Rilutek (View Usage). After Rilutek was administered, patient had the following side effects: pneumonia (What is pneumonia?) on Dec 09, 2009 from AUSTRALIA Additional patient health information: Male patient , 77 years of age, . Rilutek dosage: . During the same period patient was treated with ACTONEL (View Actonel Review and Actonel Label ), CARTIA /AUS/ (View Cartia /aus/ Review and Cartia /aus/ Label ), HERBAL PREPARATION (View Herbal Preparation Review and Herbal Preparation Label ).

6497584-9 | Cyanosis, Sulphaemoglobinaemia
Adverse event was reported on Dec 09, 2009 by a Female patient taking Rilutek (View Usage) (Dosage: ) was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?), muscle twitching and. Location: FRANCE , 50 years of age, Patient experienced the following unwanted or unexpected effects: cyanosis, sulphaemoglobinaemia. During the same period patient was treated with MIOREL (View Miorel Review and Miorel Label ), LIORESAL ^NOVARTIS^ (View Lioresal ^novartis^ Review and Lioresal ^novartis^ Label ). Patient was hospitalized.

6441982-6 | Chronic Respiratory Failure
on Nov 10, 2009 Male patient from AUSTRALIA , 74 years of age, was treated with Rilutek (View Usage). Patient had the following side effects: chronic respiratory failure. Rilutek dosage: Dose: Unk.

6430040-2 | Condition Aggravated, Pemphigoid, Respiratory Failure
on Oct 29, 2009 Male patient from JAPAN , 76 years of age, weighting 105.8 lb, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?), upper respiratory tract inflammation and was treated with Rilutek (View Usage). After Rilutek was administered, patient had the following side effects: condition aggravated, pemphigoid, respiratory failure. Rilutek dosage: Dose Quantity: 100. During the same period patient was treated with MUCOSOLVAN (View Mucosolvan Review and Mucosolvan Label ), CELTECT (View Celtect Review and Celtect Label ), METHYCOBAL /00056201/ (View Methycobal /00056201/ Review and Methycobal /00056201/ Label ), ASTOMIN /00426502/ (View Astomin /00426502/ Review and Astomin /00426502/ Label ), CRAVIT (View Cravit Review and Cravit Label ). Patient was hospitalized.

6426689-3 |
Patient was taking Rilutek (View Usage). on Oct 28, 2009 from AUSTRALIA Additional patient health information: Male patient , 74 years of age, . Rilutek dosage: Dose: Unk.

6349061-3 | Pemphigoid
Adverse event was reported on Sep 02, 2009 by a Female patient taking Rilutek (View Usage) (Dosage: ) . Location: JAPAN , 73 years of age, Patient had the following side effects: pemphigoid. During the same period patient was treated with METHYCOBAL /00056201/ (View Methycobal /00056201/ Review and Methycobal /00056201/ Label ), VITAMIN B NOS (View Vitamin B Nos Review and Vitamin B Nos Label ), MAGMITT (View Magmitt Review and Magmitt Label ), LAXOBERON (View Laxoberon Review and Laxoberon Label ).

6349060-1 | Condition Aggravated, Pemphigoid, Respiratory Failure
on Sep 02, 2009 Male patient from JAPAN , 76 years of age, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and was treated with Rilutek (View Usage). After Rilutek was administered, patient had the following side effects: condition aggravated, pemphigoid, respiratory failure. Rilutek dosage: Dose Quantity: 100. During the same period patient was treated with CELTECT (View Celtect Review and Celtect Label ), METHYCOBAL /00056201/ (View Methycobal /00056201/ Review and Methycobal /00056201/ Label ), MUCOSOLVAN (View Mucosolvan Review and Mucosolvan Label ), ASTOMIN /00426502/ (View Astomin /00426502/ Review and Astomin /00426502/ Label ).

6343865-9 | Pemphigoid
on Sep 02, 2009 Female patient from JAPAN , 61 years of age, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and was treated with Rilutek (View Usage). Patient experienced the following unwanted or unexpected effects: pemphigoid. Rilutek dosage: . During the same period patient was treated with METHYCOBAL /00056201/ (View Methycobal /00056201/ Review and Methycobal /00056201/ Label ). Patient was hospitalized.

6287072-7 | Prostate Cancer Metastatic
Patient was taking Rilutek (View Usage). Patient had the following side effects: prostate cancer metastatic on Jul 16, 2009 from DENMARK Additional patient health information: Male patient , 62 years of age, weighting 172.0 lb, . Rilutek dosage: . During the same period patient was treated with BAKLOFEN (View Baklofen Review and Baklofen Label ).

6260058-4 | Depressed Level Of Consciousness, Hepatitis Fulminant
Adverse event was reported on Jun 30, 2009 by a Female patient taking Rilutek (View Usage) (Dosage: ) was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?), constipation (What is constipation?) and. Location: JAPAN , 39 years of age, weighting 99.21 lb, After Rilutek was administered, patient had the following side effects: depressed level of consciousness, hepatitis fulminant. During the same period patient was treated with METHYCOBAL /00056201/ (View Methycobal /00056201/ Review and Methycobal /00056201/ Label ), MAGMITT (View Magmitt Review and Magmitt Label ), JUVELA /00110503/ (View Juvela /00110503/ Review and Juvela /00110503/ Label ).

6259224-3 |
on Jun 30, 2009 Male patient from AUSTRALIA , 85 years of age, was treated with Rilutek (View Usage). . Rilutek dosage: . During the same period patient was treated with DILATREND (View Dilatrend Review and Dilatrend Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ZIMSTAT (View Zimstat Review and Zimstat Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ), LASIX (View Lasix Review and Lasix Label ), COVERSYL /00790701/ (View Coversyl /00790701/ Review and Coversyl /00790701/ Label ), PANAMAX (View Panamax Review and Panamax Label ).

6254876-6 | Depressed Level Of Consciousness, Hepatitis Fulminant
on Jun 24, 2009 Female patient from JAPAN , 39 years of age, weighting 99.21 lb, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and was treated with Rilutek (View Usage). Patient had the following side effects: depressed level of consciousness, hepatitis fulminant. Rilutek dosage: . During the same period patient was treated with METHYCOBAL /00056201/ (View Methycobal /00056201/ Review and Methycobal /00056201/ Label ), MAGLAX (View Maglax Review and Maglax Label ), MAGMITT (View Magmitt Review and Magmitt Label ), JUVELA /00110503/ (View Juvela /00110503/ Review and Juvela /00110503/ Label ).

6247163-3 |
Patient was taking Rilutek (View Usage). on Jun 18, 2009 from AUSTRALIA Additional patient health information: Male patient , 85 years of age, . Rilutek dosage: . During the same period patient was treated with DILATREND (View Dilatrend Review and Dilatrend Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ZIMSTAT (View Zimstat Review and Zimstat Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ), LASIX (View Lasix Review and Lasix Label ), COVERSYL /00790701/ (View Coversyl /00790701/ Review and Coversyl /00790701/ Label ), PANAMAX (View Panamax Review and Panamax Label ).

6236313-0 | Depressed Level Of Consciousness, Hepatitis Fulminant
Adverse event was reported on Jun 10, 2009 by a Female patient taking Rilutek (View Usage) (Dosage: ) was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and. Location: JAPAN , 39 years of age, Patient experienced the following unwanted or unexpected effects: depressed level of consciousness, hepatitis fulminant. During the same period patient was treated with METHYCOBAL /00056201/ (View Methycobal /00056201/ Review and Methycobal /00056201/ Label ), MAGLAX (View Maglax Review and Maglax Label ). Patient was hospitalized.

6234578-2 | Pyrexia
on Jun 15, 2009 Male patient from JAPAN , 56 years of age, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and was treated with Rilutek (View Usage). Patient had the following side effects: pyrexia. Rilutek dosage: . Patient was hospitalized.

6228573-7 | Amyotrophic Lateral Sclerosis, Condition Aggravated, Disease Progression, Pregnancy
on Jun 10, 2009 Female patient from JAPAN , 38 years of age, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and was treated with Rilutek (View Usage). After Rilutek was administered, patient had the following side effects: amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?), condition aggravated, disease progression, pregnancy (What is pregnancy?). Rilutek dosage: .

6220925-4 |
Patient was taking Rilutek (View Usage). on Jun 03, 2009 from JAPAN Additional patient health information: Female patient , 38 years of age, . Rilutek dosage: .

6216446-5 | Burning Sensation, Erythema, Pain, Pulmonary Embolism
Adverse event was reported on May 28, 2009 by a Male patient taking Rilutek (View Usage) (Dosage: ) was diagnosed with pulmonary embolism (What is pulmonary embolism?), pain (What is pain?), anxiety (What is anxiety?), constipation (What is constipation?), gastrointestinal disorder, hypertension, bronchial disorder and. Location: CANADA , 53 years of age, Patient had the following side effects: burning sensation, erythema, pain (What is pain?), pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), EMPRACET 30 (View Empracet-30 Review and Empracet-30 Label ), XANAX (View Xanax Review and Xanax Label ), COLACE (Dose: 200 To 400) (View Colace Review and Colace Label ), PENTASA (Dose: 2000mg Am And 2500mg Hs) (View Pentasa Review and Pentasa Label ), ATACAND (View Atacand Review and Atacand Label ), TRIATEC 30 (Dose: 300+30) (View Triatec-30 Review and Triatec-30 Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ).

6212893-6 | Interstitial Lung Disease, Respiratory Failure
on May 29, 2009 Male patient from JAPAN , 67 years of age, weighting 108.0 lb, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?), depression (What is depression?), dizziness (What is dizziness?), bronchitis (What is bronchitis?), insomnia and was treated with Rilutek (View Usage). After Rilutek was administered, patient had the following side effects: interstitial lung disease, respiratory failure. Rilutek dosage: . During the same period patient was treated with TAKEPRON (Route: Gastrostomy Tube) (View Takepron Review and Takepron Label ), DOGMATYL (Route: Gastrostomy Tube) (View Dogmatyl Review and Dogmatyl Label ), FLIVAS (Route: Gastrostomy Tube) (View Flivas Review and Flivas Label ), DEANOSARL (Route: Gastrostomy Tube) (View Deanosarl Review and Deanosarl Label ), MUCODYNE (Route: Gastrostomy Tube) (View Mucodyne Review and Mucodyne Label ), GASMOTIN (Route: Gastrostomy Tube) (View Gasmotin Review and Gasmotin Label ), LOXONIN /00890701/ (Route: Gastrostomy Tube) (View Loxonin /00890701/ Review and Loxonin /00890701/ Label ), LEDOLPER (Route: Gastrostomy Tube) (View Ledolper Review and Ledolper Label ).

6210680-6 | Myocardial Infarction
on May 25, 2009 Female patient from AUSTRALIA , 74 years of age, was treated with Rilutek (View Usage). Patient experienced the following unwanted or unexpected effects: myocardial infarction. Rilutek dosage: . During the same period patient was treated with LYRICA (View Lyrica Review and Lyrica Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), PRAMIN /00041901/ (View Pramin /00041901/ Review and Pramin /00041901/ Label ).

6210679-X | Balance Disorder, Fall, Somnolence
Patient was taking Rilutek (View Usage). Patient had the following side effects: balance disorder, fall (What is fall?), somnolence on May 20, 2009 from UNITED STATES Additional patient health information: Male patient , 83 years of age, . Rilutek dosage: . During the same period patient was treated with TOPROL XL (View Toprol-xl Review and Toprol-xl Label ). Patient was hospitalized.

6197633-1 | Myocardial Infarction
Adverse event was reported on May 12, 2009 by a Female patient taking Rilutek (View Usage) (Dosage: ) . Location: AUSTRALIA , 74 years of age, After Rilutek was administered, patient had the following side effects: myocardial infarction. During the same period patient was treated with LYRICA (View Lyrica Review and Lyrica Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), PRAMIN /00041901/ (View Pramin /00041901/ Review and Pramin /00041901/ Label ).

6188470-2 | Suffocation Feeling, Tachycardia
on Apr 30, 2009 Male patient from FRANCE , 60 years of age, weighting 134.5 lb, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?), diabetes mellitus and was treated with Rilutek (View Usage). Patient experienced the following unwanted or unexpected effects: suffocation feeling, tachycardia. Rilutek dosage: Dose: 50-50. During the same period patient was treated with EZETROL (View Ezetrol Review and Ezetrol Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), SERTRALINE HCL (View Sertraline Hcl Review and Sertraline Hcl Label ).

6152634-4 | Burning Sensation, Erythema, Pain, Pulmonary Embolism
on Apr 02, 2009 Male patient from CANADA , 53 years of age, was diagnosed with pain (What is pain?), constipation (What is constipation?), gastrointestinal disorder and was treated with Rilutek (View Usage). Patient had the following side effects: burning sensation, erythema, pain (What is pain?), pulmonary embolism (What is pulmonary embolism?). Rilutek dosage: . During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), EMPRACET 30 (View Empracet-30 Review and Empracet-30 Label ), XANAX (View Xanax Review and Xanax Label ), COLACE (View Colace Review and Colace Label ), PENTASA (Dose: 2000mg Am And 2500mg Hs) (View Pentasa Review and Pentasa Label ).

6146540-9 | Dehydration, Hypotension, Hypovolaemia, Medical Device Complication, Transient Ischaemic Attack
Patient was taking Rilutek (View Usage). After Rilutek was administered, patient had the following side effects: dehydration, hypotension, hypovolaemia, medical device complication, transient ischaemic attack on Mar 26, 2009 from AUSTRALIA Additional patient health information: Male patient , 59 years of age, . Rilutek dosage: . Patient was hospitalized.

6124336-1 | Prostate Cancer Metastatic
Adverse event was reported on Mar 10, 2009 by a Male patient taking Rilutek (View Usage) (Dosage: ) . Location: DENMARK , 62 years of age, weighting 172.0 lb, Patient experienced the following unwanted or unexpected effects: prostate cancer metastatic. During the same period patient was treated with BAKLOFEN (View Baklofen Review and Baklofen Label ).

6111889-2 | Prostate Cancer Metastatic
on Mar 03, 2009 Male patient from DENMARK , 62 years of age, weighting 172.0 lb, was treated with Rilutek (View Usage). Patient had the following side effects: prostate cancer metastatic. Rilutek dosage: . During the same period patient was treated with BAKLOFEN (View Baklofen Review and Baklofen Label ).

6111887-9 | Transient Ischaemic Attack
on Mar 02, 2009 Male patient from AUSTRALIA , 59 years of age, was treated with Rilutek (View Usage). After Rilutek was administered, patient had the following side effects: transient ischaemic attack. Rilutek dosage: . Patient was hospitalized.

6102425-5 | Diarrhoea, Leukocytoclastic Vasculitis, Pyrexia
Patient was taking Rilutek (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, leukocytoclastic vasculitis, pyrexia on Feb 25, 2009 from DENMARK Additional patient health information: Male patient , 59 years of age, weighting 165.3 lb, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and. Rilutek dosage: . Patient was hospitalized.

6092193-8 | Pyrexia
Adverse event was reported on Feb 19, 2009 by a Male patient taking Rilutek (View Usage) (Dosage: ) was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and. Location: JAPAN , 56 years of age, Patient had the following side effects: pyrexia. Patient was hospitalized.

6045438-4 | Abortion Spontaneous, Dyskinesia, Off Label Use, Tardive Dyskinesia
on Jan 14, 2009 Female patient from UNITED STATES , weighting 145.3 lb, was diagnosed with depression (What is depression?) and was treated with Rilutek (View Usage). After Rilutek was administered, patient had the following side effects: abortion spontaneous, dyskinesia, off label use, tardive dyskinesia. Rilutek dosage: . During the same period patient was treated with VALIUM (Dose: Unk) (View Valium Review and Valium Label ), ZOLOFT (Dose: Unk) (View Zoloft Review and Zoloft Label ), IMITREX (Dose: Unk) (View Imitrex Review and Imitrex Label ), ROZEREM (Dose: Unk) (View Rozerem Review and Rozerem Label ), ALLEGRA /01314201/ (Dose: Unk) (View Allegra /01314201/ Review and Allegra /01314201/ Label ).

6042190-3 | Diarrhoea, Leukocytoclastic Vasculitis, Pyrexia
on Jan 07, 2009 Male patient from DENMARK , 59 years of age, weighting 165.3 lb, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and was treated with Rilutek (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, leukocytoclastic vasculitis, pyrexia. Rilutek dosage: . Patient was hospitalized.

6036013-6 | International Normalised Ratio Increased
Patient was taking Rilutek (View Usage). Patient had the following side effects: international normalised ratio increased on Dec 19, 2008 from FRANCE Additional patient health information: Female patient , 80 years of age, . Rilutek dosage: . During the same period patient was treated with ANTITHROMBOTIC AGENTS (View Antithrombotic Agents Review and Antithrombotic Agents Label ).